<DOC>
	<DOC>NCT01353287</DOC>
	<brief_summary>The primary objective of this clinical trial is to evaluate safety of patients who underwent Transcatheter Aortic Valve Intervention (TAVI) during a live case or video-taped transmission as compared to those without procedure transmission.</brief_summary>
	<brief_title>Transcatheter Aortic Valve Intervention-Live Transmission</brief_title>
	<detailed_description>A series of sites from outside the US, where the Edwards-Sapien and CoreValve devices are approved for commercial sale and implantation, will be recruited to retrospectively identify and extract in-hospital data of a patient who underwent TAVI during a live or video-taped procedure and a matched patient who underwent TAVI without transmission of the procedure.</detailed_description>
	<criteria>Cases Subjects &gt; 18 years of age, male or female Subject had live case or videotaped transmission of TAVI procedure with: EdwardsSapien transfemoral approach, EdwardsSapien transapical approach, or CoreValve transfemoral approach Controls Subjects &gt; 18 years of age, male or female Subject underwent TAVI without procedure transmission and had: EdwardsSapien transfemoral approach, EdwardsSapien transapical approach, or CoreValve transfemoral approach Subjects will be matched to Cases upon the following: STS SCORE +/ 2points Date of TAVI procedure +/ 4weeks The first attending for the TAVI procedure Access site for TAVI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Transcatheter Aortic Valve Intervention (TAVI)</keyword>
	<keyword>Live case transmission</keyword>
</DOC>